SureTrader
Home > Boards > US Listed > Biotechs > Peregrine Pharmaceuticals (PPHM)

To quote Mark Twain, "The rumors of my

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stoneroad Member Profile
Member Level 
Followed By 37
Posts 3,840
Boards Moderated 0
Alias Born 02/12/09
160x600 placeholder
Four Biotech Small Caps with Near Term Catalysts to Keep on Your Radar "InvestorsHub NewsWire" - 1/27/2016 8:00:00 AM
Peregrine Pharmaceuticals to Present at Two Upcoming Cancer Immunotherapy Conferences "GlobeNewswire Inc." - 1/20/2016 8:05:00 AM
Peregrine Pharmaceuticals Provides Update on Planned Expansion of Bavituximab Clinical Program in Lung, Breast and Other Canc... "GlobeNewswire Inc." - 1/11/2016 8:05:00 AM
Peregrine Pharmaceuticals and National Comprehensive Cancer Network (NCCN) Form Clinical Collaboration to Evaluate Novel Canc... "GlobeNewswire Inc." - 1/6/2016 8:05:00 AM
Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2016 and Recent Developments "GlobeNewswire Inc." - 12/10/2015 4:05:00 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 12/7/2015 4:05:00 PM
It's the Little Things That Matter for Peregrine Pharmaceuticals "The Motley Fool" - 12/4/2015 10:46:03 AM
Peregrine to Report Financial Results for Second Quarter of Fiscal Year 2016 After Market Close on December 10, 2015 "GlobeNewswire Inc." - 12/3/2015 4:05:00 PM
Peregrine Pharmaceuticals to Participate in Two Upcoming Life Science Investor Conferences "GlobeNewswire Inc." - 11/23/2015 8:05:00 AM
Feature Analyst Alert and 4 Brief Updates "InvestorsHub NewsWire" - 11/10/2015 8:00:00 AM
New Preclinical Data Presented at SITC Annual Meeting Highlight Bavituximab’s Enhanced Anti-Tumor Activity When Combined Wi... "GlobeNewswire Inc." - 11/9/2015 8:05:00 AM
Peregrine Pharmaceuticals' Stock Sank in September: Is It Now a Buy? "The Motley Fool" - 10/17/2015 7:03:03 AM
AstraZeneca and Peregrine Pharmaceuticals Expand Ongoing Immuno-Oncology Collaboration to Include Phase II Lung Cancer Combin... "GlobeNewswire Inc." - 10/15/2015 8:05:00 AM
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2016 and Recent Developments "GlobeNewswire Inc." - 9/21/2015 8:46:28 PM
Biotechnology Stocks Technical Study -- Exelixis, XOMA Corp., Enzon Pharma, Peregrine Pharma, and StemCells "PR Newswire (US)" - 9/21/2015 8:50:00 AM
3 Key Takeaways From Peregrine Pharmaceuticals' Fourth-Quarter Results "The Motley Fool" - 7/15/2015 5:10:02 PM
Peregrine Pharmaceuticals Q4 Earnings Preview "The Motley Fool" - 7/10/2015 4:02:02 PM
Small Cap Stocks to Watch in Biotech "The Motley Fool" - 6/30/2015 12:02:03 PM
Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports "InvestorsHub NewsWire" - 6/15/2015 7:00:00 AM
1 Drug Will Make or Break These 3 Biotech Stocks "The Motley Fool" - 6/13/2015 7:18:02 AM
Special Profile & Four Companies Where Investors are Anticipating Success "InvestorsHub NewsWire" - 6/3/2015 7:00:00 AM
Peregrine Pharmaceuticals' Immuno-Oncology Agent Bavituximab to be Highlighted in Three Presentations at 2015 ASCO Annual Mee... "GlobeNewswire Inc." - 5/13/2015 5:00:00 PM
*Special Analyst Alert* and 4 Companies that are Worth a Look "InvestorsHub NewsWire" - 5/13/2015 7:00:00 AM
Preclinical Data Presented at AACR Demonstrate Synergistic Anti-Tumor Effects of Peregrine Pharmaceuticals' Phosphatidylserin... "GlobeNewswire Inc." - 4/21/2015 8:00:00 AM
Peregrine Pharmaceuticals Given a $5.00 Price Target at Roth Capital (PPHM) "Analyst Ratings Network" - 4/20/2015 3:24:37 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist